Global Preclinical Tomography System for Biopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Description

The global Preclinical Tomography System for Biopharmaceuticals market size is expected to reach $ 202.2 million by 2030, rising at a market growth of 4.1% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Preclinical Tomography System for Biopharmaceuticals is an advanced imaging technology used in research and development to visualize and analyze the distribution and effects of biopharmaceutical compounds in living organisms, typically small animals like mice or rats. This system employs tomographic imaging techniques such as PET (Positron Emission Tomography) or SPECT (Single Photon Emission Computed Tomography) to create detailed 3D images of the internal structures of the animals, aiding researchers in evaluating the efficacy and safety of potential drug candidates.

This report studies the global Preclinical Tomography System for Biopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Preclinical Tomography System for Biopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Preclinical Tomography System for Biopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Preclinical Tomography System for Biopharmaceuticals total production and demand, 2019-2030, (K Units)
Global Preclinical Tomography System for Biopharmaceuticals total production value, 2019-2030, (USD Million)
Global Preclinical Tomography System for Biopharmaceuticals production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Preclinical Tomography System for Biopharmaceuticals consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Preclinical Tomography System for Biopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Preclinical Tomography System for Biopharmaceuticals production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Preclinical Tomography System for Biopharmaceuticals production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Preclinical Tomography System for Biopharmaceuticals production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Preclinical Tomography System for Biopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bruker, MR Solutions, Scanco Medical, PerkinElmer, Trifoil Imaging, Mediso, Sedecal and MILabs, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Preclinical Tomography System for Biopharmaceuticals market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Preclinical Tomography System for Biopharmaceuticals Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Preclinical Tomography System for Biopharmaceuticals Market, Segmentation by Type
    CT
    SPECT
    Others

Global Preclinical Tomography System for Biopharmaceuticals Market, Segmentation by Application
    Hospital
    Research Institute
    Other

Companies Profiled:
    Bruker
    MR Solutions
    Scanco Medical
    PerkinElmer
    Trifoil Imaging
    Mediso
    Sedecal
    MILabs

Key Questions Answered
1. How big is the global Preclinical Tomography System for Biopharmaceuticals market?
2. What is the demand of the global Preclinical Tomography System for Biopharmaceuticals market?
3. What is the year over year growth of the global Preclinical Tomography System for Biopharmaceuticals market?
4. What is the production and production value of the global Preclinical Tomography System for Biopharmaceuticals market?
5. Who are the key producers in the global Preclinical Tomography System for Biopharmaceuticals market?

Table of Contents

1 Supply Summary
    1.1 Preclinical Tomography System for Biopharmaceuticals Introduction
    1.2 World Preclinical Tomography System for Biopharmaceuticals Supply & Forecast
        1.2.1 World Preclinical Tomography System for Biopharmaceuticals Production Value (2019 & 2023 & 2030)
        1.2.2 World Preclinical Tomography System for Biopharmaceuticals Production (2019-2030)
        1.2.3 World Preclinical Tomography System for Biopharmaceuticals Pricing Trends (2019-2030)
    1.3 World Preclinical Tomography System for Biopharmaceuticals Production by Region (Based on Production Site)
        1.3.1 World Preclinical Tomography System for Biopharmaceuticals Production Value by Region (2019-2030)
        1.3.2 World Preclinical Tomography System for Biopharmaceuticals Production by Region (2019-2030)
        1.3.3 World Preclinical Tomography System for Biopharmaceuticals Average Price by Region (2019-2030)
        1.3.4 North America Preclinical Tomography System for Biopharmaceuticals Production (2019-2030)
        1.3.5 Europe Preclinical Tomography System for Biopharmaceuticals Production (2019-2030)
        1.3.6 China Preclinical Tomography System for Biopharmaceuticals Production (2019-2030)
        1.3.7 Japan Preclinical Tomography System for Biopharmaceuticals Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Preclinical Tomography System for Biopharmaceuticals Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Preclinical Tomography System for Biopharmaceuticals Major Market Trends

2 Demand Summary
    2.1 World Preclinical Tomography System for Biopharmaceuticals Demand (2019-2030)
    2.2 World Preclinical Tomography System for Biopharmaceuticals Consumption by Region
        2.2.1 World Preclinical Tomography System for Biopharmaceuticals Consumption by Region (2019-2024)
        2.2.2 World Preclinical Tomography System for Biopharmaceuticals Consumption Forecast by Region (2025-2030)
    2.3 United States Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030)
    2.4 China Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030)
    2.5 Europe Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030)
    2.6 Japan Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030)
    2.7 South Korea Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030)
    2.8 ASEAN Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030)
    2.9 India Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030)

3 World Preclinical Tomography System for Biopharmaceuticals Manufacturers Competitive Analysis
    3.1 World Preclinical Tomography System for Biopharmaceuticals Production Value by Manufacturer (2019-2024)
    3.2 World Preclinical Tomography System for Biopharmaceuticals Production by Manufacturer (2019-2024)
    3.3 World Preclinical Tomography System for Biopharmaceuticals Average Price by Manufacturer (2019-2024)
    3.4 Preclinical Tomography System for Biopharmaceuticals Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Preclinical Tomography System for Biopharmaceuticals Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Preclinical Tomography System for Biopharmaceuticals in 2023
        3.5.3 Global Concentration Ratios (CR8) for Preclinical Tomography System for Biopharmaceuticals in 2023
    3.6 Preclinical Tomography System for Biopharmaceuticals Market: Overall Company Footprint Analysis
        3.6.1 Preclinical Tomography System for Biopharmaceuticals Market: Region Footprint
        3.6.2 Preclinical Tomography System for Biopharmaceuticals Market: Company Product Type Footprint
        3.6.3 Preclinical Tomography System for Biopharmaceuticals Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Preclinical Tomography System for Biopharmaceuticals Production Value Comparison
        4.1.1 United States VS China: Preclinical Tomography System for Biopharmaceuticals Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Preclinical Tomography System for Biopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Preclinical Tomography System for Biopharmaceuticals Production Comparison
        4.2.1 United States VS China: Preclinical Tomography System for Biopharmaceuticals Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Preclinical Tomography System for Biopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Preclinical Tomography System for Biopharmaceuticals Consumption Comparison
        4.3.1 United States VS China: Preclinical Tomography System for Biopharmaceuticals Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Preclinical Tomography System for Biopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Preclinical Tomography System for Biopharmaceuticals Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Preclinical Tomography System for Biopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production (2019-2024)
    4.5 China Based Preclinical Tomography System for Biopharmaceuticals Manufacturers and Market Share
        4.5.1 China Based Preclinical Tomography System for Biopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value (2019-2024)
        4.5.3 China Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production (2019-2024)
    4.6 Rest of World Based Preclinical Tomography System for Biopharmaceuticals Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Preclinical Tomography System for Biopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production (2019-2024)

5 Market Analysis by Type
    5.1 World Preclinical Tomography System for Biopharmaceuticals Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 CT
        5.2.2 SPECT
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Preclinical Tomography System for Biopharmaceuticals Production by Type (2019-2030)
        5.3.2 World Preclinical Tomography System for Biopharmaceuticals Production Value by Type (2019-2030)
        5.3.3 World Preclinical Tomography System for Biopharmaceuticals Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Preclinical Tomography System for Biopharmaceuticals Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Research Institute
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Preclinical Tomography System for Biopharmaceuticals Production by Application (2019-2030)
        6.3.2 World Preclinical Tomography System for Biopharmaceuticals Production Value by Application (2019-2030)
        6.3.3 World Preclinical Tomography System for Biopharmaceuticals Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Bruker
        7.1.1 Bruker Details
        7.1.2 Bruker Major Business
        7.1.3 Bruker Preclinical Tomography System for Biopharmaceuticals Product and Services
        7.1.4 Bruker Preclinical Tomography System for Biopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Bruker Recent Developments/Updates
        7.1.6 Bruker Competitive Strengths & Weaknesses
    7.2 MR Solutions
        7.2.1 MR Solutions Details
        7.2.2 MR Solutions Major Business
        7.2.3 MR Solutions Preclinical Tomography System for Biopharmaceuticals Product and Services
        7.2.4 MR Solutions Preclinical Tomography System for Biopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 MR Solutions Recent Developments/Updates
        7.2.6 MR Solutions Competitive Strengths & Weaknesses
    7.3 Scanco Medical
        7.3.1 Scanco Medical Details
        7.3.2 Scanco Medical Major Business
        7.3.3 Scanco Medical Preclinical Tomography System for Biopharmaceuticals Product and Services
        7.3.4 Scanco Medical Preclinical Tomography System for Biopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Scanco Medical Recent Developments/Updates
        7.3.6 Scanco Medical Competitive Strengths & Weaknesses
    7.4 PerkinElmer
        7.4.1 PerkinElmer Details
        7.4.2 PerkinElmer Major Business
        7.4.3 PerkinElmer Preclinical Tomography System for Biopharmaceuticals Product and Services
        7.4.4 PerkinElmer Preclinical Tomography System for Biopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 PerkinElmer Recent Developments/Updates
        7.4.6 PerkinElmer Competitive Strengths & Weaknesses
    7.5 Trifoil Imaging
        7.5.1 Trifoil Imaging Details
        7.5.2 Trifoil Imaging Major Business
        7.5.3 Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Product and Services
        7.5.4 Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Trifoil Imaging Recent Developments/Updates
        7.5.6 Trifoil Imaging Competitive Strengths & Weaknesses
    7.6 Mediso
        7.6.1 Mediso Details
        7.6.2 Mediso Major Business
        7.6.3 Mediso Preclinical Tomography System for Biopharmaceuticals Product and Services
        7.6.4 Mediso Preclinical Tomography System for Biopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Mediso Recent Developments/Updates
        7.6.6 Mediso Competitive Strengths & Weaknesses
    7.7 Sedecal
        7.7.1 Sedecal Details
        7.7.2 Sedecal Major Business
        7.7.3 Sedecal Preclinical Tomography System for Biopharmaceuticals Product and Services
        7.7.4 Sedecal Preclinical Tomography System for Biopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Sedecal Recent Developments/Updates
        7.7.6 Sedecal Competitive Strengths & Weaknesses
    7.8 MILabs
        7.8.1 MILabs Details
        7.8.2 MILabs Major Business
        7.8.3 MILabs Preclinical Tomography System for Biopharmaceuticals Product and Services
        7.8.4 MILabs Preclinical Tomography System for Biopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 MILabs Recent Developments/Updates
        7.8.6 MILabs Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Preclinical Tomography System for Biopharmaceuticals Industry Chain
    8.2 Preclinical Tomography System for Biopharmaceuticals Upstream Analysis
        8.2.1 Preclinical Tomography System for Biopharmaceuticals Core Raw Materials
        8.2.2 Main Manufacturers of Preclinical Tomography System for Biopharmaceuticals Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Preclinical Tomography System for Biopharmaceuticals Production Mode
    8.6 Preclinical Tomography System for Biopharmaceuticals Procurement Model
    8.7 Preclinical Tomography System for Biopharmaceuticals Industry Sales Model and Sales Channels
        8.7.1 Preclinical Tomography System for Biopharmaceuticals Sales Model
        8.7.2 Preclinical Tomography System for Biopharmaceuticals Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Preclinical Tomography System for Biopharmaceuticals Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Preclinical Tomography System for Biopharmaceuticals Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Preclinical Tomography System for Biopharmaceuticals Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Preclinical Tomography System for Biopharmaceuticals Production Value Market Share by Region (2019-2024)
    Table 5. World Preclinical Tomography System for Biopharmaceuticals Production Value Market Share by Region (2025-2030)
    Table 6. World Preclinical Tomography System for Biopharmaceuticals Production by Region (2019-2024) & (K Units)
    Table 7. World Preclinical Tomography System for Biopharmaceuticals Production by Region (2025-2030) & (K Units)
    Table 8. World Preclinical Tomography System for Biopharmaceuticals Production Market Share by Region (2019-2024)
    Table 9. World Preclinical Tomography System for Biopharmaceuticals Production Market Share by Region (2025-2030)
    Table 10. World Preclinical Tomography System for Biopharmaceuticals Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Preclinical Tomography System for Biopharmaceuticals Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Preclinical Tomography System for Biopharmaceuticals Major Market Trends
    Table 13. World Preclinical Tomography System for Biopharmaceuticals Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Preclinical Tomography System for Biopharmaceuticals Consumption by Region (2019-2024) & (K Units)
    Table 15. World Preclinical Tomography System for Biopharmaceuticals Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Preclinical Tomography System for Biopharmaceuticals Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Preclinical Tomography System for Biopharmaceuticals Producers in 2023
    Table 18. World Preclinical Tomography System for Biopharmaceuticals Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Preclinical Tomography System for Biopharmaceuticals Producers in 2023
    Table 20. World Preclinical Tomography System for Biopharmaceuticals Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Preclinical Tomography System for Biopharmaceuticals Company Evaluation Quadrant
    Table 22. World Preclinical Tomography System for Biopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Preclinical Tomography System for Biopharmaceuticals Production Site of Key Manufacturer
    Table 24. Preclinical Tomography System for Biopharmaceuticals Market: Company Product Type Footprint
    Table 25. Preclinical Tomography System for Biopharmaceuticals Market: Company Product Application Footprint
    Table 26. Preclinical Tomography System for Biopharmaceuticals Competitive Factors
    Table 27. Preclinical Tomography System for Biopharmaceuticals New Entrant and Capacity Expansion Plans
    Table 28. Preclinical Tomography System for Biopharmaceuticals Mergers & Acquisitions Activity
    Table 29. United States VS China Preclinical Tomography System for Biopharmaceuticals Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Preclinical Tomography System for Biopharmaceuticals Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Preclinical Tomography System for Biopharmaceuticals Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Preclinical Tomography System for Biopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Market Share (2019-2024)
    Table 37. China Based Preclinical Tomography System for Biopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Market Share (2019-2024)
    Table 42. Rest of World Based Preclinical Tomography System for Biopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Market Share (2019-2024)
    Table 47. World Preclinical Tomography System for Biopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Preclinical Tomography System for Biopharmaceuticals Production by Type (2019-2024) & (K Units)
    Table 49. World Preclinical Tomography System for Biopharmaceuticals Production by Type (2025-2030) & (K Units)
    Table 50. World Preclinical Tomography System for Biopharmaceuticals Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Preclinical Tomography System for Biopharmaceuticals Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Preclinical Tomography System for Biopharmaceuticals Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Preclinical Tomography System for Biopharmaceuticals Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Preclinical Tomography System for Biopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Preclinical Tomography System for Biopharmaceuticals Production by Application (2019-2024) & (K Units)
    Table 56. World Preclinical Tomography System for Biopharmaceuticals Production by Application (2025-2030) & (K Units)
    Table 57. World Preclinical Tomography System for Biopharmaceuticals Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Preclinical Tomography System for Biopharmaceuticals Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Preclinical Tomography System for Biopharmaceuticals Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Preclinical Tomography System for Biopharmaceuticals Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Bruker Basic Information, Manufacturing Base and Competitors
    Table 62. Bruker Major Business
    Table 63. Bruker Preclinical Tomography System for Biopharmaceuticals Product and Services
    Table 64. Bruker Preclinical Tomography System for Biopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Bruker Recent Developments/Updates
    Table 66. Bruker Competitive Strengths & Weaknesses
    Table 67. MR Solutions Basic Information, Manufacturing Base and Competitors
    Table 68. MR Solutions Major Business
    Table 69. MR Solutions Preclinical Tomography System for Biopharmaceuticals Product and Services
    Table 70. MR Solutions Preclinical Tomography System for Biopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. MR Solutions Recent Developments/Updates
    Table 72. MR Solutions Competitive Strengths & Weaknesses
    Table 73. Scanco Medical Basic Information, Manufacturing Base and Competitors
    Table 74. Scanco Medical Major Business
    Table 75. Scanco Medical Preclinical Tomography System for Biopharmaceuticals Product and Services
    Table 76. Scanco Medical Preclinical Tomography System for Biopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Scanco Medical Recent Developments/Updates
    Table 78. Scanco Medical Competitive Strengths & Weaknesses
    Table 79. PerkinElmer Basic Information, Manufacturing Base and Competitors
    Table 80. PerkinElmer Major Business
    Table 81. PerkinElmer Preclinical Tomography System for Biopharmaceuticals Product and Services
    Table 82. PerkinElmer Preclinical Tomography System for Biopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. PerkinElmer Recent Developments/Updates
    Table 84. PerkinElmer Competitive Strengths & Weaknesses
    Table 85. Trifoil Imaging Basic Information, Manufacturing Base and Competitors
    Table 86. Trifoil Imaging Major Business
    Table 87. Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Product and Services
    Table 88. Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Trifoil Imaging Recent Developments/Updates
    Table 90. Trifoil Imaging Competitive Strengths & Weaknesses
    Table 91. Mediso Basic Information, Manufacturing Base and Competitors
    Table 92. Mediso Major Business
    Table 93. Mediso Preclinical Tomography System for Biopharmaceuticals Product and Services
    Table 94. Mediso Preclinical Tomography System for Biopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Mediso Recent Developments/Updates
    Table 96. Mediso Competitive Strengths & Weaknesses
    Table 97. Sedecal Basic Information, Manufacturing Base and Competitors
    Table 98. Sedecal Major Business
    Table 99. Sedecal Preclinical Tomography System for Biopharmaceuticals Product and Services
    Table 100. Sedecal Preclinical Tomography System for Biopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Sedecal Recent Developments/Updates
    Table 102. MILabs Basic Information, Manufacturing Base and Competitors
    Table 103. MILabs Major Business
    Table 104. MILabs Preclinical Tomography System for Biopharmaceuticals Product and Services
    Table 105. MILabs Preclinical Tomography System for Biopharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 106. Global Key Players of Preclinical Tomography System for Biopharmaceuticals Upstream (Raw Materials)
    Table 107. Preclinical Tomography System for Biopharmaceuticals Typical Customers
    Table 108. Preclinical Tomography System for Biopharmaceuticals Typical Distributors
List of Figure
    Figure 1. Preclinical Tomography System for Biopharmaceuticals Picture
    Figure 2. World Preclinical Tomography System for Biopharmaceuticals Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Preclinical Tomography System for Biopharmaceuticals Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Preclinical Tomography System for Biopharmaceuticals Production (2019-2030) & (K Units)
    Figure 5. World Preclinical Tomography System for Biopharmaceuticals Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Preclinical Tomography System for Biopharmaceuticals Production Value Market Share by Region (2019-2030)
    Figure 7. World Preclinical Tomography System for Biopharmaceuticals Production Market Share by Region (2019-2030)
    Figure 8. North America Preclinical Tomography System for Biopharmaceuticals Production (2019-2030) & (K Units)
    Figure 9. Europe Preclinical Tomography System for Biopharmaceuticals Production (2019-2030) & (K Units)
    Figure 10. China Preclinical Tomography System for Biopharmaceuticals Production (2019-2030) & (K Units)
    Figure 11. Japan Preclinical Tomography System for Biopharmaceuticals Production (2019-2030) & (K Units)
    Figure 12. Preclinical Tomography System for Biopharmaceuticals Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030) & (K Units)
    Figure 15. World Preclinical Tomography System for Biopharmaceuticals Consumption Market Share by Region (2019-2030)
    Figure 16. United States Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030) & (K Units)
    Figure 17. China Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030) & (K Units)
    Figure 18. Europe Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030) & (K Units)
    Figure 19. Japan Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030) & (K Units)
    Figure 22. India Preclinical Tomography System for Biopharmaceuticals Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Preclinical Tomography System for Biopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Preclinical Tomography System for Biopharmaceuticals Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Preclinical Tomography System for Biopharmaceuticals Markets in 2023
    Figure 26. United States VS China: Preclinical Tomography System for Biopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Preclinical Tomography System for Biopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Preclinical Tomography System for Biopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Market Share 2023
    Figure 30. China Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Preclinical Tomography System for Biopharmaceuticals Production Market Share 2023
    Figure 32. World Preclinical Tomography System for Biopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Preclinical Tomography System for Biopharmaceuticals Production Value Market Share by Type in 2023
    Figure 34. CT
    Figure 35. SPECT
    Figure 36. Others
    Figure 37. World Preclinical Tomography System for Biopharmaceuticals Production Market Share by Type (2019-2030)
    Figure 38. World Preclinical Tomography System for Biopharmaceuticals Production Value Market Share by Type (2019-2030)
    Figure 39. World Preclinical Tomography System for Biopharmaceuticals Average Price by Type (2019-2030) & (US$/Unit)
    Figure 40. World Preclinical Tomography System for Biopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Preclinical Tomography System for Biopharmaceuticals Production Value Market Share by Application in 2023
    Figure 42. Hospital
    Figure 43. Research Institute
    Figure 44. Other
    Figure 45. World Preclinical Tomography System for Biopharmaceuticals Production Market Share by Application (2019-2030)
    Figure 46. World Preclinical Tomography System for Biopharmaceuticals Production Value Market Share by Application (2019-2030)
    Figure 47. World Preclinical Tomography System for Biopharmaceuticals Average Price by Application (2019-2030) & (US$/Unit)
    Figure 48. Preclinical Tomography System for Biopharmaceuticals Industry Chain
    Figure 49. Preclinical Tomography System for Biopharmaceuticals Procurement Model
    Figure 50. Preclinical Tomography System for Biopharmaceuticals Sales Model
    Figure 51. Preclinical Tomography System for Biopharmaceuticals Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Companies Mentioned

Bruker
MR Solutions
Scanco Medical
PerkinElmer
Trifoil Imaging
Mediso
Sedecal
MILabs